Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Diseases of Aquatic Organisms|August 16, 2002
A parvo-like virus in cultured redclaw crayfish Cherax quadricarinatus from Queensland, AustraliaRachel O Bowater, Max Wingfield, Andrew Fisk, et al.Osteoarthritis and Cartilage|July 17, 2012
Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysisA K Suokas, D A Walsh, D F McWilliams, et al.G3 (Bethesda, Md.)|May 13, 2016
The Immature Fiber Mutant Phenotype of Cotton (Gossypium hirsutum) Is Linked to a 22-bp Frame-Shift Deletion in a Mitochondria Targeted Pentatricopeptide Repeat GeneGregory N Thyssen, David D Fang, Linghe Zeng, et al.Contemporary Clinical Trials Communications|August 11, 2020
Increasing access to clinical research using an innovative mobile recruitment approach: The (MoRe) conceptDanielle Beck, Aliya Asghar, Tawni Kenworthy-Heinige, et al.Contemporary Clinical Trials Communications|May 10, 2018
A cross-cutting approach to enhancing clinical trial site success: The Department of Veterans Affairs' Network of Dedicated Enrollment Sites (NODES) modelDebra L Condon, Danielle Beck, Tawni Kenworthy-Heinige, et al.Journal of Medicinal Chemistry|February 19, 1993
Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517)S H Rosenberg, K P Spina, S L Condon, et al.International Journal of Molecular Sciences|May 28, 2022
Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver AxisManasa Sagaram, Ranganathan Parthasarathy, Sally L Condon, et al.Journal of Medicinal Chemistry|May 15, 1992
1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitorsS F Martin, R E Austin, C J Oalmann, et al.Clinical Chemistry|November 1, 1992
Effects of angiotensinase inhibitors on plasma protein binding and IC50 determinations of renin inhibitorsB D Dayton, H H Stein, J Cohen, et al.Journal of Medicinal Chemistry|May 15, 1992
Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacementW R Baker, A K Fung, H D Kleinert, et al.Pageof 3